Retrospective analysis of the effect of CAPOX and mFOLFOX6 dose intensity on survival in colorectal patients in the adjuvant setting

BACKGROUND: Despite lack of a true comparative study, the folfox (5-fluorouracil–leucovorin–oxaliplatin) and capox (capecitabine–oxaliplatin) regimens are believed to be similar in their efficacy and tolerability in the treatment of stage iii colorectal cancer. However, that belief has been disputed...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Curr Oncol
Autores principales: Mamo, A., Easaw, J., Ibnshamsah, F., Baig, A., Rho, Y.S., Kavan, T., Batist, G., Kavan, P.
Formato: Artigo
Lenguaje:Inglês
Publicado: Multimed Inc. 2016
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4900828/
https://ncbi.nlm.nih.gov/pubmed/27330345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3059
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares